BMS-986484 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Non-Small Cell Lung Cancer.

Zolacabtagene autoleucel is under clinical development by Bristol-Myers Squibb and currently in Phase I for Marginal Zone B-cell Lymphoma.

Wales playmaker Ioan Lloyd is set to sign for Cardiff, WalesOnline can reveal. The 23-year-old has made the shock decision to ...

Carolina Blue Bristol with handler Chris Speer finished first with a score of 875 after Friday night's hunt at the Grand ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...

After the "mangled" body of Rachel Siani, 21, was found in New Jersey after being thrown from a bridge, police tracked down a ...

He might have lost ground to Noah Lolesio in the race to wear the No.10 jersey against the Lions in July, but Tom Lynagh isn’t about to get bogged down by looking too far ahead. Instead, the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new challenge system will be tested, baseball will be played at an iconic NASCAR track and several superstars will chase ...

Some Pennsylvania residents were charged with crimes for their roles on Jan. 6, 2021, including members of the Proud Boys.

All Blacks legend Justin Marshall belives that New Zealand could benefit from Jordie Barrett's stint in Leinster when he ...